Skip to main content
Log in

Female Hypoactive Sexual Desire Disorder

Epidemiology Diagnosis and Treatment

  • Therapy In Practice
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

Female hypoactive sexual desire disorder (HSDD) may occur in up to one-third of adult women in the US. The essential feature of female HSDD is a deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty.

The evaluation of female HSDD generally requires careful and thoughtful consideration of the patient and the multitude of factors that impact on the various components of adult female sexual desire. Several female reproductive life experiences may uniquely affect sexual desire. These events include menstrual cycles, hormonal contraceptives, postpartum states and lactation, oophorectomy and hysterectomy, and perimenopausal and postmenopausal states. Sexual dysfunctions in women have strong positive associations with low feelings of physical and emotional satisfaction and low feelings of happiness. Thus, female HSDD can greatly impact on quality of life.

In this article, treatment options are discussed with special attention to significant reproductive life events that may impact on sexual desire in adult women. Depending on the particular phase of reproductive life that a woman is experiencing, different recommendations are made. Various options in the treatment of HSDD in women include lifestyle changes, treatment of coexisting medical or psychiatric disorders, switching or discontinuing medications that could impact on sexual desire, hormone therapy and marital therapy. Clinical trials are presently underway to assess medications that may potentially benefit female patients with HSDD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

Notes

  1. Use of tradenames is for product identification only and does not imply endorsement.

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994

    Google Scholar 

  2. Goldstein I. Female sexual arousal disorder: new insights. Int J Impot Res 2000; 12Suppl. 4: 152S–7S

    Article  Google Scholar 

  3. Graziottin A. The biological basis of female sexuality. Int Clin Psychopharmacol 1998 Jul 13; 13Suppl.6: 1S5–22S

    Google Scholar 

  4. Redmond GP. Hormones and sexual function. Int J Fertil Womens Med 1999 Jun–Aug; 44(4): 193–7

    PubMed  CAS  Google Scholar 

  5. Sarrel PM, Whitehead MI. Sex and menopause: defining the issues. Maturitas 1985 Sep; 7(3): 217–24

    Article  PubMed  CAS  Google Scholar 

  6. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990 Apr; 75Suppl.4: 26S–30S

    PubMed  CAS  Google Scholar 

  7. Stahl SM. Essential psychopharmacology: neuroscientific basis and practical applications. 2nd ed. Cambridge: Cambridge University Press, 2000

    Google Scholar 

  8. Crenshaw TL, Goldberg JP. Sexual pharmacology: drugs that affect sexual function. New York: W.W. Norton and Company, 1996

    Google Scholar 

  9. Canale D, Pistoia S. Libido and hormones. CNS Spectrums 2000 Aug; 5(8): 21–3

    PubMed  CAS  Google Scholar 

  10. Waxenberg SE, Finkbiner JA, Drellick ND, et al. The role of hormones in human behavior, 2: changes in sexual behavior in relation to vaginal smears of breast cancer patients after oophorectomy and adrenalectomy. Psychosom Med 1960; 22: 435–9

    PubMed  CAS  Google Scholar 

  11. Rako S. The hormone of desire: the truth about sexuality, menopause and testosterone. New York: Harmony Books, 1996

    Google Scholar 

  12. Basson R. The female sexual response: a different model. J Sex Marital Ther 2000 Jan–Mar; 26(1): 51–65

    Article  PubMed  CAS  Google Scholar 

  13. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537–44

    Article  PubMed  CAS  Google Scholar 

  14. DeCherney AH. Hormone receptors and sexuality in the human female. J Womens Health Gend Based Med 2000; 9(1): S9–13

    Article  PubMed  Google Scholar 

  15. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985 Jul–Aug; 47(4): 339–51

    PubMed  CAS  Google Scholar 

  16. Sherwin BB. Changes in sexual behavior as a function of plasma sex steroid levels in post-menopausal women. Maturitas 1985 Sep; 7(3): 225–33

    Article  PubMed  CAS  Google Scholar 

  17. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000 Sep 7; 343(10): 682–8

    Article  PubMed  CAS  Google Scholar 

  18. Clayton AH, Clavet GJ, McGarvey EL, et al. Assessment of sexual functioning during the menstrual cycle. J Sex Marital Ther 1999 Oct–Dec; 25(4): 281–91

    Article  PubMed  CAS  Google Scholar 

  19. Gitlin MJ. Effects of depression and antidepressants on sexual functioning. Bull Menninger Clin 1995 Spring; 59(2): 232–48

    PubMed  CAS  Google Scholar 

  20. Warnock JK, Blake CF. Psychiatric aspects of hormonal contraception. In: Clayton AH, Kornstein SG, editors. Women’s textbook of mental health. New York: Guilford Press, 2002: 114–31

    Google Scholar 

  21. Graham CA, Sherwin BB. The relationship between mood and sexuality in women using oral contraceptive as a treatment for premenstrual symptoms. Psychoneuroendocrinology 1993; 18(4): 273–81

    Article  PubMed  CAS  Google Scholar 

  22. Graham CA, Ramos R, Bancroft J, et al. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception 1995 Dec; 52(6): 363–9

    Article  PubMed  CAS  Google Scholar 

  23. Slap GB. Oral contraceptives and depression: impact, prevalence and cause. J Adolesc Health Care 1981 Sep; 2(1): 53–64

    Article  PubMed  CAS  Google Scholar 

  24. Bancroft J, Sherwin BB, Alexander GM, et al. Oral contraceptives, androgens, and the sexuality of young women. II: the role of androgens. Arch Sex Behav 1991 Apr; 20(2): 121–35

    CAS  Google Scholar 

  25. Coenen CM, Thomas CM, Borm GF, et al. Changes in androgens during treatment with four low-dose contraceptives. Contraception 1996 Mar; 53(3): 171–6

    Article  PubMed  CAS  Google Scholar 

  26. Hendrick V, Altshuler LL, Suri R. Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics 1998 Mar–Apr; 39(2): 93–101

    Article  PubMed  CAS  Google Scholar 

  27. Pfaus JG, Everitt BJ. The psychopharmacology of sexual behaviour. In: Bloom FE, Kupfer D, editors. Psychopharmacology. New York: Raven Press, 1995: 743–58

    Google Scholar 

  28. American College of Obstetricians and Gynecologists. Issues in women’s health. Washington, DC: Office of Public Information, 1992

    Google Scholar 

  29. Heiman JR, Meston CM. Evaluating sexual dysfunction in women. Clin Obstet Gynaecol 1997 Sep; 40(3): 616–29

    Article  CAS  Google Scholar 

  30. Warnock JK. Hormonal aspects of sexual function in women: treatment advantages with hormone replacement therapy. Primary Psychiatry 2001; 8(4): 60–4

    Google Scholar 

  31. Davis SR. Androgen treatment in women. Med J Aust 1999; 170(11): 545–9

    PubMed  CAS  Google Scholar 

  32. Fava M, Rankin MA, Alpert JE, et al. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom 1998; 67(6): 328–31

    Article  PubMed  CAS  Google Scholar 

  33. Nurnberg HG, Lauriello J, Hensley PL, et al. Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients. J Clin Psychiatry 1999 Jan; 60(1): 33–5

    Article  PubMed  CAS  Google Scholar 

  34. Salerian AJ, Deibler WE, Vittone BJ, et al. Sildenafil for psychotropic-induced sexual dysfunction in 31 women and 61 men. J Sex Marital Ther 2000 Apr–Jun; 26(2): 133–40

    Article  PubMed  CAS  Google Scholar 

  35. Segraves RT, Croft H, Kavoussi R, et al. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women. J Sex Marital Ther 2001; 27(3): 303–16

    Article  PubMed  CAS  Google Scholar 

  36. Clayton AH, McGarvey EL, Warnock JK, et al. Bupropion as a treatment for SSRI-induced sexual dysfunction. Female Sexual Functioning Forum; 2000 Oct 26–29; Boston (MA)

Download references

Acknowledgements

No funding was used to assist in the preparation of this manuscript. The author is a speaker for and has received research grants from GlaxoSmithKline, Pfizer and Solvay.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julia ‘Jill’ K. Warnock.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Warnock, J.‘.K. Female Hypoactive Sexual Desire Disorder. Mol Diag Ther 16, 745–753 (2002). https://doi.org/10.2165/00023210-200216110-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-200216110-00003

Keywords

Navigation